{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:19:14Z","timestamp":1788297554080,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T00:00:00Z","timestamp":1410825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00198-014-2862-7","type":"journal-article","created":{"date-parts":[[2014,9,15]],"date-time":"2014-09-15T09:41:54Z","timestamp":1410774114000},"page":"395-405","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Plasma FGF23 levels and heart rate variability in patients with stage 5 CKD"],"prefix":"10.1007","volume":"26","author":[{"given":"L.-N.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-Y.","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-J.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.-X.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-F.","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.-B.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-J.","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-Y.","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.-M.","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.-N.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,16]]},"reference":[{"issue":"13","key":"2862_CR1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296\u20131305","journal-title":"N Engl J Med"},{"issue":"1 Suppl","key":"2862_CR2","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2013.11.001","volume":"63","author":"AJ Collins","year":"2014","unstructured":"Collins AJ et al (2014) US renal data system 2013 annual data report. Am J Kidney Dis 63(1 Suppl):A7","journal-title":"Am J Kidney Dis"},{"key":"2862_CR3","unstructured":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl, 2009 (113): p. S1-130"},{"issue":"4","key":"2862_CR4","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","volume":"6","author":"J Cunningham","year":"2011","unstructured":"Cunningham J, Locatelli F, Rodriguez M (2011) Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 6(4):913\u2013921","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"2862_CR5","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1681\/ASN.V1091972","volume":"10","author":"D Rubinger","year":"1999","unstructured":"Rubinger D et al (1999) Heart rate variability during chronic hemodialysis and after renal transplantation: studies in patients without and with systemic amyloidosis. J Am Soc Nephrol 10(9):1972\u20131981","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"2862_CR6","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2215\/CJN.10381012","volume":"8","author":"J Zhang","year":"2013","unstructured":"Zhang J et al (2013) Parathyroidectomy and heart rate variability in patients with stage 5 CKD. Clin J Am Soc Nephrol 8(8):1378\u20131387","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"2862_CR7","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1172\/JCI36479","volume":"118","author":"LD Quarles","year":"2008","unstructured":"Quarles LD (2008) Endocrine functions of bone in mineral metabolism regulation. J Clin Invest 118(12):3820\u20133828","journal-title":"J Clin Invest"},{"issue":"2","key":"2862_CR8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","volume":"314","author":"T Shimada","year":"2004","unstructured":"Shimada T et al (2004) FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem Biophys Res Commun 314(2):409\u2013414","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"2862_CR9","first-page":"4003","volume":"117","author":"IZ Ben-Dov","year":"2007","unstructured":"Ben-Dov IZ et al (2007) The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117(12):4003\u20134008","journal-title":"J Clin Invest"},{"issue":"3","key":"2862_CR10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T et al (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19(3):429\u2013435","journal-title":"J Bone Miner Res"},{"issue":"23","key":"2862_CR11","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","volume":"305","author":"T Isakova","year":"2011","unstructured":"Isakova T et al (2011) Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 305(23):2432\u20132439","journal-title":"JAMA"},{"issue":"10","key":"2862_CR12","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","volume":"22","author":"J Kendrick","year":"2011","unstructured":"Kendrick J et al (2011) FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol 22(10):1913\u20131922","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"2862_CR13","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","volume":"152","author":"BD Parker","year":"2010","unstructured":"Parker BD et al (2010) The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the heart and soul study. Ann Intern Med 152(10):640\u2013648","journal-title":"Ann Intern Med"},{"issue":"19","key":"2862_CR14","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","volume":"119","author":"OM Gutierrez","year":"2009","unstructured":"Gutierrez OM et al (2009) Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 119(19):2545\u20132552","journal-title":"Circulation"},{"issue":"7","key":"2862_CR15","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s00198-011-1838-0","volume":"23","author":"L Desjardins","year":"2012","unstructured":"Desjardins L et al (2012) FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int 23(7):2017\u20132025","journal-title":"Osteoporos Int"},{"issue":"Suppl 2","key":"2862_CR16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ndt\/11.supp2.16","volume":"11","author":"B Charra","year":"1996","unstructured":"Charra B et al (1996) Clinical assessment of dry weight. Nephrol Dial Transplant 11(Suppl 2):16\u201319","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2862_CR17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/HYPERTENSIONAHA.109.143974","volume":"55","author":"AD Sinha","year":"2010","unstructured":"Sinha AD, Light RP, Agarwal R (2010) Relative plasma volume monitoring during hemodialysis AIDS the assessment of dry weight. Hypertension 55(2):305\u2013311","journal-title":"Hypertension"},{"key":"2862_CR18","doi-asserted-by":"crossref","unstructured":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis, 2003. 42(4 Suppl 3): p. S1-201","DOI":"10.1016\/S0272-6386(03)00905-3"},{"issue":"8","key":"2862_CR19","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/lary.21023","volume":"120","author":"M Kara","year":"2010","unstructured":"Kara M et al (2010) Evaluation of intraoperative parathormone measurement for predicting successful surgery in patients undergoing subtotal\/total parathyroidectomy due to secondary hyperparathyroidism. Laryngoscope 120(8):1538\u20131544","journal-title":"Laryngoscope"},{"issue":"2","key":"2862_CR20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/ndt\/18.2.318","volume":"18","author":"H Fukuta","year":"2003","unstructured":"Fukuta H et al (2003) Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis. Nephrol Dial Transplant 18(2):318\u2013325","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"2862_CR21","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1093\/ndt\/gfq234","volume":"25","author":"ME Roumelioti","year":"2010","unstructured":"Roumelioti ME et al (2010) Abnormal nocturnal heart rate variability response among chronic kidney disease and dialysis patients during wakefulness and sleep. Nephrol Dial Transplant 25(11):3733\u20133741","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"2862_CR22","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/ndt\/14.6.1480","volume":"14","author":"J Hayano","year":"1999","unstructured":"Hayano J et al (1999) Prognostic value of heart rate variability during long-term follow-up in chronic haemodialysis patients with end-stage renal disease. Nephrol Dial Transplant 14(6):1480\u20131488","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2862_CR23","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2337\/diacare.28.3.668","volume":"28","author":"EB Schroeder","year":"2005","unstructured":"Schroeder EB et al (2005) Diabetes, glucose, insulin, and heart rate variability: the atherosclerosis risk in communities (ARIC) study. Diabetes Care 28(3):668\u2013674","journal-title":"Diabetes Care"},{"issue":"7","key":"2862_CR24","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1359\/jbmr.2003.18.7.1227","volume":"18","author":"TJ Weber","year":"2003","unstructured":"Weber TJ et al (2003) Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res 18(7):1227\u20131234","journal-title":"J Bone Miner Res"},{"key":"2862_CR25","doi-asserted-by":"crossref","unstructured":"Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J, 1996. 17(3): p. 354\u201381","DOI":"10.1093\/oxfordjournals.eurheartj.a014868"},{"issue":"10","key":"2862_CR26","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2215\/CJN.03080410","volume":"5","author":"CT Chan","year":"2010","unstructured":"Chan CT et al (2010) Determinants of cardiac autonomic dysfunction in ESRD. Clin J Am Soc Nephrol 5(10):1821\u20131827","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"2862_CR27","doi-asserted-by":"crossref","first-page":"c147","DOI":"10.1159\/000337571","volume":"120","author":"PA Sarafidis","year":"2012","unstructured":"Sarafidis PA et al (2012) Prevalence, patterns of treatment, and control of hypertension in predialysis patients with chronic kidney disease. Nephron Clin Pract 120(3):c147\u2013c155","journal-title":"Nephron Clin Pract"},{"issue":"2","key":"2862_CR28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1365-2710.2002.00404.x","volume":"27","author":"HC Routledge","year":"2002","unstructured":"Routledge HC, Chowdhary S, Townend JN (2002) Heart rate variability\u2014a therapeutic target? J Clin Pharm Ther 27(2):85\u201392","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"2862_CR29","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","volume":"16","author":"B Kestenbaum","year":"2005","unstructured":"Kestenbaum B et al (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16(2):520\u2013528","journal-title":"J Am Soc Nephrol"},{"issue":"10\u201311","key":"2862_CR30","first-page":"368","volume":"105","author":"H Nasri","year":"2004","unstructured":"Nasri H, Baradaran A (2004) Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Bratisl Lek Listy 105(10\u201311):368\u2013373","journal-title":"Bratisl Lek Listy"},{"issue":"1\u20132","key":"2862_CR31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.autneu.2004.08.002","volume":"115","author":"G Polak","year":"2004","unstructured":"Polak G et al (2004) Effect of parathormone on heart rate variability in hemodialysis patients. Auton Neurosci 115(1\u20132):94\u201398","journal-title":"Auton Neurosci"},{"issue":"6","key":"2862_CR32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Gutierrez","year":"2008","unstructured":"Gutierrez OM et al (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359(6):584\u2013592","journal-title":"N Engl J Med"},{"issue":"7","key":"2862_CR33","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","volume":"16","author":"O Gutierrez","year":"2005","unstructured":"Gutierrez O et al (2005) Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16(7):2205\u20132215","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2862_CR34","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.cmet.2008.10.009","volume":"8","author":"N Wang","year":"2008","unstructured":"Wang N et al (2008) Vascular PPARgamma controls circadian variation in blood pressure and heart rate through Bmal1. Cell Metab 8(6):482\u2013491","journal-title":"Cell Metab"},{"issue":"4","key":"2862_CR35","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/01.psy.0000170335.92770.7a","volume":"67","author":"PJ Gianaros","year":"2005","unstructured":"Gianaros PJ et al (2005) A greater reduction in high-frequency heart rate variability to a psychological stressor is associated with subclinical coronary and aortic calcification in postmenopausal women. Psychosom Med 67(4):553\u2013560","journal-title":"Psychosom Med"},{"issue":"2","key":"2862_CR36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000189804","volume":"18","author":"JC Longenecker","year":"2009","unstructured":"Longenecker JC et al (2009) Association of low heart rate variability with atherosclerotic cardiovascular disease in hemodialysis patients. Med Princ Pract 18(2):85\u201392","journal-title":"Med Princ Pract"},{"issue":"22","key":"2862_CR37","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.ehj.2003.09.010","volume":"24","author":"FN Saleh","year":"2003","unstructured":"Saleh FN et al (2003) Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 24(22):2054\u20132060","journal-title":"Eur Heart J"},{"issue":"11","key":"2862_CR38","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C et al (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121(11):4393\u20134408","journal-title":"J Clin Invest"},{"issue":"2","key":"2862_CR39","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijcard.2008.03.039","volume":"135","author":"BM Cheung","year":"2009","unstructured":"Cheung BM, Ong KL, Wong LY (2009) Elevated serum alkaline phosphatase and peripheral arterial disease in the United States National Health and Nutrition Examination Survey 1999\u20132004. Int J Cardiol 135(2):156\u2013161","journal-title":"Int J Cardiol"},{"issue":"8","key":"2862_CR40","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/ndt\/gfh892","volume":"20","author":"P Evenepoel","year":"2005","unstructured":"Evenepoel P et al (2005) Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. Nephrol Dial Transplant 20(8):1714\u20131720","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2862_CR41","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1177\/147323001103900333","volume":"39","author":"J Naranda","year":"2011","unstructured":"Naranda J, Ekart R, Pecovnik-Balon B (2011) Total parathyroidectomy with forearm autotransplantation as the treatment of choice for secondary hyperparathyroidism. J Int Med Res 39(3):978\u2013987","journal-title":"J Int Med Res"},{"issue":"6","key":"2862_CR42","first-page":"878","volume":"16","author":"KM Chow","year":"2003","unstructured":"Chow KM et al (2003) Improved health-related quality of life and left ventricular hypertrophy among dialysis patients treated with parathyroidectomy. J Nephrol 16(6):878\u2013885","journal-title":"J Nephrol"},{"key":"2862_CR43","doi-asserted-by":"crossref","unstructured":"Takahashi H et al (2014) Impact of parathyroidectomy on serum FGF23 and soluble Klotho in hemodialysis patients with severe secondary hyperparathyroidism. J Clin Endocrinol Metab: p. jc20134050","DOI":"10.1210\/jc.2013-4050"},{"issue":"4","key":"2862_CR44","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jamcollsurg.2011.12.046","volume":"214","author":"J Sharma","year":"2012","unstructured":"Sharma J et al (2012) Improved long-term survival of dialysis patients after near-total parathyroidectomy. J Am Coll Surg 214(4):400\u2013407, discussion 407\u20138","journal-title":"J Am Coll Surg"},{"issue":"2","key":"2862_CR45","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.surg.2005.08.036","volume":"139","author":"ML Richards","year":"2006","unstructured":"Richards ML et al (2006) Parathyroidectomy in secondary hyperparathyroidism: is there an optimal operative management? Surgery 139(2):174\u2013180","journal-title":"Surgery"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2862-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-014-2862-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2862-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T01:05:40Z","timestamp":1650157540000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-014-2862-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,16]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["2862"],"URL":"https:\/\/doi.org\/10.1007\/s00198-014-2862-7","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,16]]}}}